drugset / Trial / NCT00034983

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)

NCT00034983

Phase 3 Completed 900 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

A clinical study to determine the efficacy and safety of an investigational medication (MK0869) in the treatment of depression

Timeline

Start
2001-10-29
Primary completion
2003-12-29
Completion
2003-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified
Subject Paroxetine Small molecule